IRIS
RUCCI, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.830
EU - Europa 3.090
AS - Asia 1.456
OC - Oceania 10
SA - Sud America 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.817
IE - Irlanda 960
CN - Cina 791
TR - Turchia 524
IT - Italia 444
DE - Germania 420
SE - Svezia 347
UA - Ucraina 305
GB - Regno Unito 286
FI - Finlandia 150
FR - Francia 107
SG - Singapore 50
VN - Vietnam 49
IN - India 22
BE - Belgio 19
CZ - Repubblica Ceca 16
RU - Federazione Russa 11
AU - Australia 9
CA - Canada 9
NL - Olanda 8
KR - Corea 7
BR - Brasile 5
IL - Israele 4
PL - Polonia 4
MX - Messico 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
JP - Giappone 2
KZ - Kazakistan 2
RO - Romania 2
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
IM - Isola di Man 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 9.397
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.202
Chandler 1.039
Dublin 958
Boardman 261
Izmir 260
Nanjing 239
San Mateo 227
Wilmington 168
Lawrence 165
Princeton 165
New York 144
L’Aquila 131
Ashburn 111
Ann Arbor 106
Nanchang 85
Milan 81
L'aquila 67
Beijing 58
Shenyang 52
Dong Ket 48
Woodbridge 47
Seattle 44
Tianjin 43
Bremen 42
Hebei 40
Singapore 35
Verona 35
Guangzhou 34
Kitzingen 33
Des Moines 31
Kunming 31
Mountain View 29
Jiaxing 28
Shanghai 28
Norwalk 24
Jinan 22
Brussels 19
Dearborn 19
Falls Church 19
Los Angeles 19
Changsha 15
Dallas 15
Brno 14
Lanzhou 14
Ningbo 14
Zhengzhou 13
Rome 12
Pescara 11
Taizhou 11
Tappahannock 11
Helsinki 10
Philadelphia 10
Munich 9
Fremont 8
Hangzhou 8
West Jordan 8
Changchun 7
Pune 7
Washington 7
Aquila 6
Grafing 6
Little Rock 6
Auburn Hills 5
Houston 5
Lappeenranta 5
Düsseldorf 4
Francavilla Al Mare 4
Fuzhou 4
Redmond 4
Shangdi 4
Strasbourg 4
Zola Predosa 4
Cagliari 3
Caserta 3
Haikou 3
Naples 3
Phoenix 3
Plymouth 3
Polska 3
Xian 3
Beauharnois 2
Brisbane 2
Cava de' Tirreni 2
Chicago 2
Chongqing 2
Doral 2
Dubai 2
Edinburgh 2
Hanover 2
Harbin 2
London 2
Manchester 2
Melbourne 2
Menlo Park 2
Mexico 2
Monserrato 2
Nerviano 2
Pisa 2
Recife 2
Redwood City 2
Totale 6.518
Salva come PNG Salva come JPEG
Nome #
(0) Save to: more options The matrix proline/arginine-rich end leucine-rich repeat protein (PRELP) inhibits osteoclastogenesis inactivating NF-kappaB signal 307
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 98
Ontogenesis and cell specific localization of Fas ligand expression in the rat testis 95
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 92
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 90
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 83
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 81
Apoptosi e spermatogenesi: implicazioni fisiopatologiche 80
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 79
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 79
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 78
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 78
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 76
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 75
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 75
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 75
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 74
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 74
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 74
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 73
The "love-hate" relationship between osteoclasts and bone matrix 73
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 71
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 71
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 70
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 70
A six-gene signature predicting breast cancer lung metastasis 70
Non-conventional role of haemoglobin beta in breast malignancy 70
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 69
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 69
Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity 69
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 69
Murine models of breast cancer bone metastasis. 69
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 69
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 68
Bone cells and the mechanisms of bone remodelling 68
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 67
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 67
C-SRC inhibition decreases breast cancer-induced lethality and incidence of experimental bone metastases in Balb nu/nu mice 66
the effect of microgravity on osteoblast metabolism 66
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 66
Regulation by thyroid hormone of expression of basement membrane components in rat Sertoli cells 65
Imbalance of osteoclastogenesis-regulating factors in celiac disease 65
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 65
Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis 65
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 64
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 64
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 64
The "soft" side of the bone: unveiling its endocrine functions. 64
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 63
A model for in vitro three dimensional cultures of osteoblast-like cells 62
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 62
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 61
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 61
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 61
A set of genes expressed in breast cancer bone metastases discloses predisposition to generate metastases in multiple organs 60
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 60
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 60
Effectiveness Of Osteotropic Nanoparticles On Bone Metastases 60
Osteomimicry: how tumor cells try to deceive the bone 58
A Combined Fc-OPG/hPTH(1-34) Therapy to Restore Impaired Skeletal Growth and Bone Loss in a Mouse Model of IL-6 Dependent Juvenile Inflammatory Diseases 58
Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma 58
Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and –beta during human testicular development and disease 57
Bone and bone marrow: the same organ 57
c-Src inhibition as a possible therapy against human breast cancer and bone metastases. 57
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 57
Alternative TrkA splicing and Cancer 56
Thyroid hormone modulation of aromatase activity and expression in mouse granulosa cells 56
Cytokine imbalance in Celiac disease and parallel direct stimulation of osteoclastogenesis and osteoblast activity in vitro. 56
Osteoclast receptors and signaling 56
A new heterozygote mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1) impairs vescicular acidification and reduces tartrate-resistant acid phosphatase activity in osteoclasts 55
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 55
Regulatory loops involving IGFBP5 account for a fine tuning regulation of osteoblast and osteoclast activity in the context of the IL-6 pathway 55
REGULATORY LOOPS INVOLVING IGFBP5 ACCOUNT FOR A FINE TUNING REGULATION OF OSTEOBLAST ACTIVITY 54
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 54
Lipocalin 2 is a novel mechanoresponding gene involved in osteoblast differentiation and osteoblast-osteoclast cross-talk 54
Microgravity accelerates differentiation, induces apoptosis and stimulates interleukin 6 expression in osteoblast-like cells 53
EFFECTS OF 1D11 AN ANTIBODY AGAINST TRANSFORMING GROWTH FACTOR BETA (TGF-B) ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 53
Experimental bone lytic lesion in prostate cancer metastasis is generayed through enhanced osteoblasts-mediated osteoclastogenesis 53
Inhibition of tyrosine kinase c-Src improves experimental breast cancer metastatic disease. Implication for therapy 53
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 53
Gene microarray analysis in mouse osteoblasts reveals sets of relevant mrnas regulated under modeled microgravity 52
Molecular biology of bone remodelling 52
Osteoblast deficiency in sox4 heterozygous mice. 52
Ontogenic pattern of thyroid hormone receptor expression in the human testis 51
OSTEOCLAST ALPHAV BETA3 INTEGRIN-INDUCED ERK1/2 ACTIVATION IS INTRACELLULAR CA2+/C-SRC-DEPENDENT, SHC/RAS/RAF-I-INDEPENDENT, AND IS TRIGGERED BY ENGAGEMENT OF PKCALPHA 51
Erk-dependent cytosolic phospholipase A2 activity is induced by CD95 ligand cross-linking in the mouse derived Sertoli cell line TM4 and is required to trigger apoptosis in CD95 bearing cells 51
Localization and expression of thyroid hormone receptors in normal and neoplastic human thyroid 51
Osteoblast and osteocyte: games without frontiers 51
Ontogeny and regulation of variant thyroid hormone receptor isoforms in developing rat testis 51
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 51
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 51
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 51
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice 50
beta-arrestin2 inhibits PTH-stimulated osteoclastogenesis and cortical bone remodeling in response to low calcium diet 50
PKCalpha is downstream of alphavbeta3 integrin and contributes to adhesion-induced ERKI/2 activation in osteoclasts. 50
Effects of bone-targeted nanoparticles on bone metastasis 50
inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases 50
Ontogenesi del sistema FASL/FAS nel testicolo: implicazioni fisiologiche e fisiopatologiche. 50
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 50
Clinical, genetic and cellular analysis of forty-nine osteopetrotic patients: implications for diagnosis and treatment 49
Totale 6.571
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020985 0 7 149 7 1 212 238 8 159 30 11 163
2020/20211.292 29 155 0 163 154 35 164 9 163 45 291 84
2021/2022916 44 96 136 58 38 25 20 61 70 22 79 267
2022/20232.962 202 143 29 323 315 331 12 214 1.236 21 86 50
2023/2024928 228 55 42 119 69 212 7 43 4 25 16 108
2024/202585 54 31 0 0 0 0 0 0 0 0 0 0
Totale 9.528